| |
| |
|
| Insider
Information: |
Pace Gary W |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
863,822 |
|
|
Indirect Shares
|
540,919 |
|
|
| Direct
Value |
$23,064,175 |
|
|
|
Indirect Value
|
$20,463,073 |
|
|
| Total
Shares |
1,404,741 |
|
|
| Total
Value |
$43,527,248 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -87.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ResMed Inc |
RMD |
Director |
2018-05-08 |
100,578 |
2015-01-26 |
93,158 |
Premium* |
|
|
Celsion Corp |
CLSN |
Director |
2008-12-04 |
43,356 |
2003-12-22 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2024-03-08 |
22,127 |
2011-11-21 |
0 |
Premium* |
|
|
Cardiff Oncology Inc |
CRDF |
Director |
2023-12-19 |
697,761 |
2020-05-11 |
447,761 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2023-12-19 |
4 |
B |
$1.37 |
$41,100 |
D/D |
30,000 |
697,761 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2023-11-10 |
4 |
B |
$0.98 |
$22,491 |
D/D |
22,950 |
667,761 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2022-09-15 |
4 |
B |
$1.71 |
$256,500 |
D/D |
150,000 |
644,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-09-21 |
4 |
B |
$6.75 |
$202,500 |
D/D |
30,000 |
494,811 |
2.39 |
% |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-23 |
4 |
B |
$10.20 |
$102,300 |
D/D |
10,000 |
464,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-18 |
4 |
B |
$10.54 |
$31,660 |
D/D |
3,000 |
454,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2021-03-04 |
4 |
B |
$9.27 |
$13,898 |
D/D |
1,500 |
451,811 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-09-16 |
4 |
B |
$5.69 |
$14,527 |
D/D |
2,550 |
450,311 |
2.39 |
- |
|
| CRDF |
Cardiff Oncology Inc |
Director |
– • – |
2020-05-11 |
4 |
B |
$1.34 |
$600,000 |
I/I |
447,761 |
447,761 |
2.1 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2010-02-19 |
4 |
OE |
$13.28 |
$424,992 |
D/D |
32,000 |
189,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2006-03-07 |
4 |
A |
$15.52 |
$225,445 |
D/D |
14,530 |
176,196 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2006-08-21 |
4 |
S |
$42.12 |
$155,681 |
D/D |
(3,696) |
172,500 |
|
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2009-05-11 |
4 |
OE |
$8.50 |
$90,661 |
D/D |
10,666 |
168,166 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2007-03-06 |
4 |
S |
$46.25 |
$277,654 |
D/D |
(6,000) |
166,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2007-03-07 |
4 |
S |
$47.20 |
$141,827 |
D/D |
(3,000) |
163,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2007-03-08 |
4 |
S |
$47.27 |
$207,995 |
D/D |
(4,400) |
159,100 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2022-02-28 |
4 |
OE |
$11.02 |
$315,624 |
D/D |
28,641 |
158,171 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2007-03-09 |
4 |
S |
$47.14 |
$75,419 |
D/D |
(1,600) |
157,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2007-08-10 |
4 |
D |
$43.21 |
$6,806,174 |
I/I |
(157,500) |
157,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2009-05-11 |
4 |
S |
$39.95 |
$426,133 |
D/D |
(10,666) |
157,500 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2010-02-19 |
4 |
S |
$57.21 |
$1,830,816 |
D/D |
(32,000) |
157,500 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-05-11 |
4 |
OE |
$29.90 |
$209,300 |
D/D |
7,000 |
144,690 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,775 |
141,450 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2011-06-22 |
4 |
OE |
$13.05 |
$835,200 |
D/D |
64,000 |
141,273 |
0 |
- |
|
| RMD |
ResMed Inc |
Director |
– • – |
2015-01-26 |
4 |
OE |
$16.50 |
$791,904 |
I/I |
48,000 |
141,158 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
